bpc 157 sfd BPC-157 PURE Oral Spray BPC-157 Research Peptide 5mg &
Description
Discontinue use and seek medical advice if unexpected swelling, fever, or persistent pain occurs
In the FDAs September 27, 2024 update, BPC-157 and Thymosin Beta-4, Fragment (LKKTETQ) appear under Category 2
We use our extensive knowledge about IV therapy to offer patients the best possible treatment
The most commonly reported side effects are mild and transient, including injection site reactions (redness, slight swelling, or tenderness), mild headaches during the initial days of use, and occasional dizziness or lightheadedness, particularly when starting the peptide
